よくある質問

What is Belantamab Mafodotin used for?

An antibody-drug conjugate that links an anti-BCMA antibody to a cytotoxic agent, delivering the toxin directly to multiple myeloma cells that express the BCMA surface protein. When the conjugate binds BCMA, the toxin is internalized and kills the cancer cell.

Is Belantamab Mafodotin an approved drug?

Yes, Belantamab Mafodotin is an approved drug. It has reached clinical phase 4. It is classified as a Antibody drug conjugate.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298209. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.